Echobiotech Financial Consultants Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 0.30 M
About Echobiotech Financial Consultants
Echobiotech Financial Consultants Private Limited (EFCPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 October 2013 and has a history of 11 years and four months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹0.30 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Ramanahalli Shivanna and Vijaya Gowda serve as directors at the Company.
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74900KA2013PTC071409
- Company No.
071409
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Oct 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Echobiotech Financial Consultants?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramanahalli Shivanna  | Director | 11-Oct-2013 | Current |
| Vijaya Gowda | Director | 11-Oct-2013 | Current |
Financial Performance of Echobiotech Financial Consultants.
Echobiotech Financial Consultants Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Echobiotech Financial Consultants?
In 2017, Echobiotech Financial Consultants had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rrr Global Advisors Private LimitedRamanahalli Shivanna is a mutual person
Charges (Loans)
₹0
₹0.30 M
Charges Breakdown by Lending Institutions
- Canara Bank : 0.03 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Mar 2016 | Canara Bank | ₹0.30 M | Satisfied |
How Many Employees Work at Echobiotech Financial Consultants?
Unlock and access historical data on people associated with Echobiotech Financial Consultants, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Echobiotech Financial Consultants, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Echobiotech Financial Consultants's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.